3545-41-3 Usage
Structure
A benzoic acid core with a dichloroacetyl group attached to the hydroxyl group
Usage
In organic synthesis as a reagent for introducing the dichloroacetyl group into various molecules
Pharmacological properties
Studied for potential antibacterial and antifungal activities
Research and development
Used in the development of new pharmaceuticals and agrochemicals
Check Digit Verification of cas no
The CAS Registry Mumber 3545-41-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,5,4 and 5 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 3545-41:
(6*3)+(5*5)+(4*4)+(3*5)+(2*4)+(1*1)=83
83 % 10 = 3
So 3545-41-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H6Cl2O4/c10-7(11)9(14)15-6-4-2-1-3-5(6)8(12)13/h1-4,7H,(H,12,13)
3545-41-3Relevant academic research and scientific papers
Synthesis of Covalent Conjugates of Dichloroacetic Acid with Polyfunctional Compounds
Bazanov, D. R.,Lozinskaya, N. A.,Maximova, N. A.,Seliverstov, M. Yu.,Sosonyuk, S. E.,Zefirov, N. A.
, p. 1834 - 1840 (2021/12/22)
Abstract: The development of prodrugs with an ester bond is classical tool to enhance the bioavailability of pharmaceutical compounds including readily ionizable molecules, such as acids or phenols. In this work, we studied the introduction of a dichloroa
Chloroethyl acyloxy salicylic acid derivatives use in medicine
-
Paragraph 0053; 0054, (2019/03/26)
The invention relates to a salicylic acid derivative preparation and its new use of development, in particular to chloroethyl acyloxy salicylic acid derivatives (synthetic route thereof and structure are as follows expressed) in the treatment of cancer an
